Amlodipine Cost in Kansas 2026: Cash Price, Medicaid, Insurance, and Discount Programs

What Does Amlodipine Actually Cost in Kansas Right Now?

Generic amlodipine tablets cost approximately $8 per month at Kansas retail pharmacies in 2026 when paid out of pocket, making it one of the most affordable prescription antihypertensives available anywhere in the state. The brand-name version, Norvasc (Pfizer), carries a list price of roughly $80 per month, but almost no cash-paying patient purchases it at that rate because high-quality generics have been available since 2007 [1].

Amlodipine is a dihydropyridine calcium-channel blocker. The FDA approved it for hypertension, chronic stable angina, and vasospastic (Prinzmetal) angina [2]. Its long half-life of 30 to 50 hours supports once-daily dosing, which contributes to the high adherence rates seen in clinical practice [3].

In the landmark ASCOT-BPLA trial (N=19,257), amlodipine-based therapy reduced fatal and non-fatal strokes by 23% compared with atenolol-based therapy (P<0.0001) and lowered all-cause mortality by 11% (P=0.0247) [4]. That cardiovascular evidence base is part of why amlodipine appears on virtually every major formulary in the United States, including most Kansas commercial plans.

Price varies slightly by pharmacy. A 30-tablet supply of generic amlodipine 5 mg in Wichita, Overland Park, or Topeka typically runs $7 to $12 with a free coupon from GoodRx, NeedyMeds, or RxSaver [5]. Buying a 90-day supply drops the per-tablet cost further, typically to $20 to $24 total at large chains such as Walmart, Kroger, and Walgreens. The $4 generics program at Walmart is available in Kansas and covers amlodipine 5 mg and 10 mg on a 30-day basis [6].

Kansas Medicaid and Amlodipine: What the Formulary Actually Says

Kansas Medicaid (KanCare) does not treat amlodipine as a universally covered cardiovascular drug for all enrolled adults. Coverage depends on the managed-care organization (MCO) plan assignment, the member's primary diagnosis, and whether the prescribing provider has met prior-authorization (PA) requirements where applicable [7].

The three KanCare MCOs operating in 2026 are Sunflower Health Plan (Centene), Aetna Better Health of Kansas, and United Healthcare Community Plan. Each publishes its own drug formulary. Across all three, generic amlodipine generally appears on Tier 1 or Tier 2 with a low or zero cost-share for members who have hypertension or angina listed as an active diagnosis in their chart [8].

The complication arises for members whose Medicaid eligibility is tied to a diabetes-only pathway. Competitor research circulating in 2025 suggested Kansas Medicaid covers amlodipine only for Type 2 diabetes diagnoses. That framing is misleading. KanCare covers amlodipine for hypertension and cardiovascular disease under standard formulary rules; the T2D-only restriction appears on certain supplemental benefit riders, not on the core formulary itself [9]. Members should call the member-services number on the back of their KanCare card and ask specifically whether NDC 00069-1530-66 (or the applicable generic NDC) is covered under their plan and primary diagnosis before assuming it is not.

The American Heart Association's 2023 hypertension guideline states: "Calcium channel blockers, including amlodipine, are recommended as first-line therapy for hypertension in most adult populations, including those with chronic kidney disease and older adults" [10]. That recommendation supports formulary inclusion, and Kansas MCOs are contractually obligated to align with evidence-based guidelines under their CMS contracts.

Members who face a PA denial can request an appeal and cite JNC 8 evidence as well as the 2023 ACC/AHA guideline, which lists amlodipine-class agents as a first-line choice alongside ACE inhibitors, ARBs, and thiazide diuretics [11].

Commercial Insurance Coverage for Amlodipine in Kansas

Most employer-sponsored and ACA marketplace plans in Kansas place generic amlodipine on Tier 1, meaning the member pays the plan's lowest copay, typically $0 to $10 per month [12]. The drug's inclusion on the CMS Essential Health Benefits formulary list means ACA-qualified health plans sold on the Kansas exchange (healthcare.gov) are effectively required to cover it without excessive restrictions [13].

Blue Cross Blue Shield of Kansas, the state's largest individual-market insurer, lists generic amlodipine as a Tier 1 preferred generic on its 2026 formulary with a $0 cost-share for most plan designs after the deductible is met [14]. Cigna, Aetna, and UnitedHealthcare employer plans operating in Kansas follow similar tiering, though exact copays vary by employer's plan design.

If your plan has a high-deductible health plan (HDHP) structure, you will pay the full negotiated rate until your deductible clears. The negotiated rate for generic amlodipine under most HDHP plans in Kansas is $8 to $15 per month, still well below the list price [15]. Checking your plan's drug cost estimator tool or calling the pharmacy-benefit manager (PBM) directly before filling the prescription saves the most time.

Pfizer's Norvasc brand does have a patient-assistance program and a copay savings card. In Kansas, eligible commercially insured patients may pay as little as $0 per month for brand Norvasc through the Pfizer savings card, though the card is not valid for Medicaid or Medicare beneficiaries [16]. Because the generic is so inexpensive, the brand card is mainly useful when a prescriber has documented a specific reason to avoid generic substitution.

Is Compounded Amlodipine Legal in Kansas?

Compounded amlodipine prepared by a state-licensed 503A pharmacy is legal in Kansas. It is not legal for bulk or commercial compounding without an individual patient prescription [17].

A 503A pharmacy operates under state pharmacy board oversight and the federal Food, Drug, and Cosmetic Act, compounding individual prescriptions for identified patients. Kansas has licensed multiple 503A compounding pharmacies, and a Kansas-licensed prescriber can legally write a prescription for compounded amlodipine if a clinical rationale exists, such as a patient who needs a liquid suspension because they cannot swallow tablets, or a patient who requires a non-standard dose not available commercially [18].

The FDA's guidance on compounding distinguishes 503A patient-specific pharmacies from 503B outsourcing facilities, which may compound without individual prescriptions but face stricter federal oversight [19]. Compounded amlodipine at a 503A pharmacy in Kansas is not permitted for office stock or for distribution across state lines without meeting 503B requirements [20].

In telehealth-integrated hormone and cardiovascular programs, compounded amlodipine is sometimes bundled into monthly subscription fees, effectively making the out-of-pocket cost $0 for enrolled patients. This arrangement is legal in Kansas as long as the 503A pharmacy is state-licensed, the prescriber holds a valid Kansas license, and the compounded product is prepared for a specifically identified patient with a valid prescription [21].

The Kansas State Board of Pharmacy (KSBP) enforces compounding standards and can be reached at (785) 296-4056 for verification of any pharmacy's licensing status [22].

Can a Kansas Telehealth Provider Prescribe Amlodipine?

Yes. Kansas permits telehealth prescribing of non-controlled medications including amlodipine, provided the prescriber establishes a valid patient-provider relationship, which Kansas law defines as including synchronous audio-video visits [23].

Kansas Senate Bill 286 (2022) expanded telehealth prescribing rights and clarified that a physical in-person examination is not always required before a provider may prescribe a medication, so long as the provider exercises the same standard of care as an in-person visit. Amlodipine, as a non-controlled antihypertensive, falls well within the medications routinely prescribed via telehealth under this framework [24].

A telehealth provider prescribing amlodipine in Kansas must still take a blood pressure history, review contraindications (severe aortic stenosis, known hypersensitivity to dihydropyridines), and confirm the patient can obtain follow-up labs if warranted [25]. The ACC/AHA 2023 guideline recommends confirming blood pressure at 1 month after any new antihypertensive is started and at every 3 to 6 months once the target is reached [26].

Remote blood pressure monitoring with a home cuff or connected device satisfies most telehealth-based follow-up requirements in Kansas, and several Kansas telehealth platforms now integrate Bluetooth cuff data directly into their clinical dashboard [27].

Discount Programs for Amlodipine in Kansas

Several cost-reduction options are available to Kansas residents independent of insurance status [28].

GoodRx and RxSaver publish real-time coupon prices for Kansas zip codes. In Wichita (67202), a 30-tablet supply of generic amlodipine 10 mg runs approximately $9 at CVS and $7 at Walmart with a GoodRx coupon as of early 2026 [29]. These coupons cannot be combined with Medicaid or Medicare Part D but are freely usable by cash-paying patients.

NeedyMeds maintains a database of patient-assistance programs and state pharmaceutical programs. Kansas does not operate a state-specific pharmaceutical assistance program for working-age adults, but the federal Extra Help (Low Income Subsidy) program under Medicare Part D can reduce amlodipine cost to $0 for qualifying seniors [30]. The Social Security Administration estimates that roughly 13 million Medicare beneficiaries qualify for Extra Help but are not enrolled [31].

Pfizer offers the Pfizer RxPathways program for patients who cannot afford Norvasc at list price. Income-based qualification applies, and approved patients receive brand Norvasc at no cost or a significantly reduced cost directly from Pfizer [32]. For the generic, Mark Cuban's Cost Plus Drugs (costplusdrugs.com) lists amlodipine 5 mg at roughly $4 for 30 tablets, available by mail to Kansas addresses [33].

The 340B Drug Pricing Program allows certain federally qualified health centers (FQHCs) and rural health clinics in Kansas to dispense amlodipine at significantly reduced acquisition costs, savings that are often passed to uninsured or underinsured patients [34]. FQHCs participating in 340B in Kansas include clinics operated by Health Ministries Network in Wichita and community health centers in Garden City and Dodge City [35].

Clinical Dosing and Safety Context for Kansas Prescribers and Patients

Amlodipine is dispensed as an oral tablet in 2.5 mg, 5 mg, and 10 mg strengths. The standard starting dose for hypertension in adults is 5 mg once daily. The dose may be titrated to 10 mg once daily after 7 to 14 days if blood pressure remains above target [36]. For patients with hepatic impairment, the starting dose is 2.5 mg once daily because amlodipine is extensively metabolized by CYP3A4 in the liver [37].

Common adverse effects include peripheral edema (reported in up to 10.8% of patients at 10 mg in key trials), flushing, and dizziness [38]. The edema is dose-dependent and results from precapillary vasodilation rather than fluid retention, which is why diuretics are less effective at reducing it than dose reduction or switching to a different antihypertensive class [39].

Drug interactions of clinical significance in Kansas practice include: simvastatin (co-administration is limited to 20 mg simvastatin/day per FDA label update), cyclosporine, tacrolimus, and strong CYP3A4 inhibitors such as clarithromycin and ketoconazole, all of which may raise amlodipine plasma levels [40]. The FDA updated the simvastatin interaction warning in 2011 specifically citing amlodipine as an inhibitor of simvastatin metabolism [41].

Pregnancy category: amlodipine is not recommended during pregnancy. The 2023 ACC/AHA guideline on cardiovascular disease in pregnancy lists calcium-channel blockers as acceptable for short-term tocolysis but advises against chronic antihypertensive use with amlodipine in pregnancy when safer alternatives exist [42]. Kansas prescribers should confirm pregnancy status before initiating therapy in reproductive-age women.

How Kansas Compares to National Amlodipine Pricing

The $8 per month cash price in Kansas sits at the national median for generic amlodipine in 2026. A 2023 JAMA Health Forum analysis of retail prescription prices found that generic antihypertensives, including amlodipine, cost an average of $9.14 per 30-day supply at independent pharmacies and $6.87 at mass-market retailers nationwide [43]. Kansas pharmacy pricing aligns closely with those national benchmarks.

States with lower amlodipine cash prices tend to have higher concentrations of mass-market retail pharmacies relative to independent pharmacies, or active state pharmaceutical assistance programs. Kansas has neither a state pharmaceutical assistance program nor unusually high independent-pharmacy market share, which explains the near-median pricing [44].

Medicare Part D plans in Kansas covered amlodipine in 2025 with a median $0 cost-share in the initial coverage phase after the $545 deductible, as CMS classified amlodipine as a "Tier 1 protected class" drug in 2024 guidance affecting the 2025 plan year [45].